View drug registration information details.


ItemsRegistration information
ID2281
No2281
Brand NameCINNARIZINE
IngredientsCINNARIZINE 25 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life4 YEARS
Pack Size1000 TABS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE SYMPTOMATIC TREATMENT OF NAUSEA AND VERTIGO DUE TO MENIERE'S DISEASE AND OTHER LABYRINTHINE DISTURBANCES, PREVENTION AND TREATMENT OF MOTION SICKNESS AND PERIPHERAL VASCULAR INSUFFICIENCY SUCH AS ARTERIOSCLEROSIS IN ELDERLY PATIENTS
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE ROUND BICONVEX TABLETS WITH A BREAKLINE ON ONE SIDE
Note
License OwnerSOKDY OSOTH IMPORT-EXPORT CO., LTD
ManufacturerUTOPAIN CO.,LTD
CountryTHAILAND
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 3543/11
FDD Registration Date18-AUG-2023
Expiry Date17-AUG-2026

Back to drug list